Dow Up0.11% Nasdaq Up0.50%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
52.04 Up 0.08(0.15%) Aug 29, 4:00PM EDT
|After Hours : 52.05 Up 0.01 (0.01%) Aug 29, 4:45PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 48,973   31,388   30,037  
Cost of Revenue5,732  3,601  4,909  
Gross Profit 43,241   27,787   25,128  
Operating Expenses
Research Development9,274  10,790  10,291  
Selling General and Administrative17,984  15,782  12,881  
Non Recurring1,040  1,022  2,834  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 14,943   193   (878)
Income from Continuing Operations
Total Other Income/Expenses Net(3,660)(1,134)(383)
Earnings Before Interest And Taxes11,283  (941)(1,261)
Interest Expense2,077  2,924  2,297  
Income Before Tax9,206  (3,865)(3,558)
Income Tax Expense374  (1,191)(13,270)
Minority Interest -   -   -  
Net Income From Continuing Ops8,832  (2,674)9,712  
Non-recurring Events
Discontinued Operations2,588  2,147  3  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 11,420   (527) 9,715  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 11,420   (527) 9,715  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.